Experimental COVID-19 Vaccine Safe, Generates Immune Response

Eurasia Review

Published

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online in The New England Journal of Medicine.

The ongoing...

Full Article